Application Nr Approved Date Route Status External Links
ANDA040254 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications & Usage This Drug Is Indicated As An Adjunct In The Treatment Of All Forms Of Parkinsonism (postencephalitic, Arteriosclerotic, And Idiopathic). It Is Often Useful As Adjuvant Therapy When Treating These Forms Of Parkinsonism With Levodopa. Additionally, It Is Indicated For The Control Of Extrapyramidal Disorders Caused By Central Nervous System Drugs Such As The Dibenzoxazepines, Phenothiazines, Thioxanthenes, And Butyrophenones.

All Formulated Excipients (0 Total)


Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Trihexyphenidyl Hydrochloride TRIHEXYPHENIDYL HYDROCHLORIDE ZINC968274